Biotechnology ETF (IBB) Trade Revision Confirmation

TheOptionPlayer.com executed the Biotechnology ETF (IBB) call adjustment. Confirmation information is displayed below. Login as a Premium Subscriber to view images/data The updated chart below confirms Biotechnology stocks continue to surge to new highs with daily opening gaps higher. The probability is this behavior will continue the for near term. See published trade https://www.theoptionplayer.com/biotech-etf-ibb-trade-revisions/ The…

Details

Biotechnology ETF (IBB) Trade Revision

Trade Summary The June 7th www.theoptionplayer.com confirmed a Biotechnology ETF (NasdaqGM: IBB) Call Credit Spread – https://www.theoptionplayer.com/biotechnology-etf-ibb-trade-entry-confirmation-3/ The chart below supports the contention the biotech sector is attempting to breakout to end a two year downtrend. As reported in an article by Alan Farley, fresh capital has been pouring into biotechnology stocks the past few…

Details

Low Risk Profit Opportunity from Incyte Corp. (INCY) Recovery Bounce

TheOptionPlayer.com sets up an Incyte Corp. (NasdaqGM: INCY) short-term (31-day) option strategy (Based on Tuesday’s closing quoted bid/ask mean) The difference between funds paid out and received is a $2.40 per share debit maximum risk for this trade. The maximum profit is approximately $7.61 per share (approx. 300%) if Incyte Corp. shares move higher prior…

Details